New York Business Journal: ShangPharma Innovation partners with Icahn School of Medicine

“Venture capital firm ShangPharma Innovation Inc. is teaming up with the Icahn School of Medicine at Mount Sinai (ISMMS) to accelerate the development of early-stage therapeutics.

As part of the multi-year strategic collaboration, ShangPharma pledges to provide multiple years of R&D funding at ISMMS’s clinical institutes in New York.”

Media Inquiries

Heidi Chokeir, Ph.D.
Canale Communications
[email protected]